Relationship Between Low‐Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid‐Lowering Strategies
- Publication date
- 9 August 2016
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'